Patricia Macanas-Pirard
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 6
- Drug-Induced Hepatotoxicity and Protection 3
- Hepatology top 10%
-
- Acute Myeloid Leukemia Research 2
-
- Inflammatory mediators and NSAID effects 6
- Drug-Induced Hepatotoxicity and Protection 3
-
- Estrogen and related hormone effects 5
-
- Cell death mechanisms and regulation 3
- Cancer therapeutics and mechanisms 1
-
- Synthesis of β-Lactam Compounds 2
-
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Richard H. HintonGeorge E.N. KassShirley C. PriceSek C. ChowKhurshid AnwarMark J. CrabtreeVictoria JohnsonBruno Nervi
- Cited by
- PharmacologyHepatologyHematology
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)PLoS ONE (2 papers)Cancer Research (2 papers)
- Partner nations
- United KingdomChileUnited States
In The Last Decade
Patricia Macanas-Pirard
13 papers receiving 380 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 148
- Hepatology 76
- Hematology 46
- Oncology 87
- Pharmacology 48
Countries citing papers authored by Patricia Macanas-Pirard
This map shows the geographic impact of Patricia Macanas-Pirard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Macanas-Pirard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Macanas-Pirard more than expected).
Fields of papers citing papers by Patricia Macanas-Pirard
This network shows the impact of papers produced by Patricia Macanas-Pirard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Macanas-Pirard. The network helps show where Patricia Macanas-Pirard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patricia Macanas-Pirard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 47 | |
| 2 | 2017 | 31 | |
| 3 | 2012 | 34 | |
| 4 | A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. | 2009 | 45 |
| 5 | A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. | 2009 | 10 |
| 6 | Paclitaxel-resistant MCF-7 cells show a caspase-less phenotype but retain sensitivity to many anticancer agents | 2008 | 1 |
| 7 | 2007 | 22 | |
| 8 | 2007 | 1 | |
| 9 | The COX-2 inhibitor celecoxib and its use in the management of prostate cancer. | 2006 | 1 |
| 10 | 2006 | 2 | |
| 11 | 2005 | 34 | |
| 12 | 2003 | 131 | |
| 13 | 2003 | 28 |
About Patricia Macanas-Pirard
Patricia Macanas-Pirard is a scholar working on Pharmacology, Pharmacology, Hematology, Hepatology and Physiology, having authored 13 papers that have together received 387 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Estrogen and related hormone effects (5 papers), Cell death mechanisms and regulation (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Acute Myeloid Leukemia Research (2 papers), Synthesis of β-Lactam Compounds (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Pharmacology (148 citations), Hepatology (76 citations), Hematology (46 citations), Oncology (87 citations) and Pharmacology (48 citations). Patricia Macanas-Pirard has collaborated with scholars based in United Kingdom, Chile and United States. Frequent co-authors include Richard H. Hinton, George E.N. Kass, Shirley C. Price, Sek C. Chow, Khurshid Anwar, Mark J. Crabtree, Victoria Johnson, Bruno Nervi, Pablo Ramírez and Helen M. Coley. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, PLoS ONE, Cancer Research, Journal of Clinical Oncology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.